1. Home
  2. SVRE vs REVB Comparison

SVRE vs REVB Comparison

Compare SVRE & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SaverOne 2014 Ltd.

SVRE

SaverOne 2014 Ltd.

HOLD

Current Price

$4.24

Market Cap

3.7M

Sector

N/A

ML Signal

HOLD

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$1.04

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVRE
REVB
Founded
2014
2020
Country
Israel
United States
Employees
35
9
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
4.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SVRE
REVB
Price
$4.24
$1.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.3K
60.5K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1,793.31
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$0.47
52 Week High
$6.30
$3.27

Technical Indicators

Market Signals
Indicator
SVRE
REVB
Relative Strength Index (RSI) 45.66 43.91
Support Level $1.03 $0.99
Resistance Level $4.92 $1.20
Average True Range (ATR) 0.61 0.07
MACD -0.14 -0.00
Stochastic Oscillator 7.39 54.10

Price Performance

Historical Comparison
SVRE
REVB

About SVRE SaverOne 2014 Ltd.

Saverone 2014 Ltd is engaged in the design, development, and commercialization of transportation and safety solutions, designed to prevent car accidents based on its patented technology of detecting, analyzing, and locating cellular phone radio frequency, or RF signals. The company is developing two product lines: the first is an In-Cabin Driver Distraction Prevention Solution (known as SaverOne system), or DDPS; and the second is an Advanced Driver-Assistance System, or ADAS, product that detects vulnerable road users, or VRUs, and provides a warning to the vehicle regarding potential collision. Geographically, Saverone generates maximum revenue from Europe and the rest from Israel.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: